Table 1.

Characteristics for the overall study population and men and women separatelya

CharacteristicOverall (n = 241)Men (n = 124)Women (n = 117)
White (%)969894
Age (yr; mean ± SD)58.7 ± 11.361.2 ± 12.156.0 ± 9.8
Weight (kg; mean ± SD)79.6 ± 15.285.5 ± 14.073.3 ± 13.8
Use of BP-lowering drugs (%)32.439.524.8
DBP (mmHg; mean ± SD)73.8 ± 8.476.7 ± 7.470.8 ± 8.3
SBP (mmHg; mean ± SD)128.1 ± 18.4131.7 ± 17.9124.2 ± 18.3
Use of lipid-lowering drugs (%)22.028.215.4
Cholesterol (mmol/L; mean ± SD)4.9 ± 1.04.7 ± 1.05.1 ± 1.0
Use of glucose-lowering drugs (%)2.54.80.0
Glucose (mmol/L; mean ± SD)5.2 ± 0.95.4 ± 1.05.1 ± 0.6
Serum creatinine (μmol/L; mean ± SD)78.1 ± 17.186.7 ± 16.769.1 ± 12.1
24-h urine collection (median [IQR])
    UAE (mg/24 h)11.5 (7.2 to 17.8)13.4 (8.7 to 22.8)8.7 (6.5 to 14.3)
    UAC (mg/L)6.5 (4.0 to 11.4)8.6 (4.9 to 13.5)5.1 (3.3 to 8.7)
    ACR (mg/g)8.3 (5.4 to 12.7)8.4 (5.3 to 12.7)7.9 (5.5 to 12.7)
    creatinine (g/24 h)1.4 (1.1 to 1.7)1.6 (1.3 to 1.9)1.1 (1.0 to 1.4)
    creatinine (g/L)0.8 (0.6 to 1.1)0.9 (0.7 to 1.3)0.7 (0.5 to 0.9)
First morning void collection (median [IQR])
    UAC (mg/L)6.1 (3.8 to 10.9)7.7 (4.6 to 12.4)4.8 (3.1 to 8.2)
    ACR (mg/g)5.7 (4.2 to 9.3)5.6 (4.0 to 10.2)5.7 (4.4 to 8.9)
    creatinine (g/L)1.0 (0.6 to 1.5)1.1 (0.7 to 1.7)0.8 (0.6 to 1.3)
Spot urine sample (median [IQR])
    UAC (mg/L)11.5 (7.4 to 24.9)12.1 (7.6 to 28.7)11.2 (6.4 to 18.2)
    ACR (mg/g)10.5 (5.7 to 18.9)10.2 (5.3 to 17.0)11.2 (6.1 to 21.6)
    creatinine (g/L)1.3 (0.74 to 1.8)1.5 (1.0 to 2.1)1.0 (0.5 to 1.7)
  • a Data are means ± SD, with the exception of albuminuria and urinary creatinine values, which are given as medians with interquartile range because of skewed data distribution. DBP; diastolic BP; IQR, interquartile range; SBP, systolic BP.